MS4A1 and B-cell chronic lymphocytic leukemia: Immunohistochemistry demonstrated strong and diffuse membranous expression of CD20 on tumor cells, confirming their B-cell lineage, along with aberrant expression of CD5, establishing the typical immunophenotype of CLL.